Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 16Lymphoma, Non-Hodgkin 10Myeloproliferative Disorders 9Multiple Myeloma 9Lymphoma, Follicular 9Leukemia, Myelomonocytic, Chronic 9Leukemia, Lymphocytic, Chronic, B-Cell 9Hodgkin Disease 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Primary Myelofibrosis 7Lymphoma, Mantle-Cell 7Leukemia, Biphenotypic, Acute 7Leukemia 7Anemia, Refractory, with Excess of Blasts 7Lymphoma, T-Cell 6Lymphoma 6Burkitt Lymphoma 6Lymphoma, Large B-Cell, Diffuse 5Anemia, Aplastic 5Waldenstrom Macroglobulinemia 4Polycythemia Vera 4Leukemia, Myeloid 4Leukemia, Lymphoid 4Hematologic Neoplasms 4Congenital Abnormalities 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3

Interventions

Azacitidine 2aldesleukin 1Whole-Body Irradiation 1Vorinostat 1Peripheral Blood Stem Cell Transplantation 1Idarubicin 1Gemtuzumab 1Filgrastim 1Etoposide 1Cytarabine 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Erythroblastic, Acute × Peripheral Blood Stem Cell Transplantation × 1 year × Clear all
NCT00534469 2025-12-02

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

City of Hope Medical Center

Phase 2 Completed
60 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡